MDxHealth (MDXH) Income towards Parent Company (2021 - 2026)

MDxHealth has reported Income towards Parent Company for 6 years, with the latest figure at $8.9 million in Q1 2026.

• Quarterly Income towards Parent Company fell 3.71% year-over-year to $8.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.7 million (down 21.5% YoY) and the FY2025 annual result came in at -$33.5 million, up 11.95% from the prior year.
• Income towards Parent Company improved to $8.9 million in Q1 2026 per MDXH's latest filing, from -$8.9 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at $18.1 billion in Q2 2022 and troughed at -$24.6 million in Q3 2025.
• A 5-year average of $1.1 billion and a median of -$8.3 million in 2022 frame the typical range for Income towards Parent Company.
• The sharpest annual moves came in 2022 and 2024: Income towards Parent Company surged 253.9% in 2022, then plunged 163.82% in 2024.
• Over 5 years, Income towards Parent Company stood at $12.4 million in 2022, then dropped by 13.81% to $10.7 million in 2023, then plunged by 163.82% to -$6.8 million in 2024, then slumped by 30.51% to -$8.9 million in 2025, then jumped by 199.32% to $8.9 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered $8.9 million, -$8.9 million, and -$24.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.